Analysis of the causal effect (outcome) of selecting dexamethasone or methylprednisolone in the treatment of all COVID-19 patients (N = 1071) | |||||
| Dexamethasone N (%) | Methylprednisolone N (%) | Difference (%) | 95% C.I. | P1 |
Outcomes2 | 453 (42.3) | 618 (57.7) | ----- |
|
|
Recovered | 159 | 238 | 3.4 | −9.4, 2.6 | 0.281 |
Residual symptoms3 | 16 (3.53) | 27 (4.36) | 0.8 | −3.4, 1.7 | 0.595 |
Needs home O2 | 233 (51.9) | 254 (41.1) | 10.3 | 4.12, 16 | <0.001 |
Death | 45 (9.9) | 99 (16.0) | 6.0 | −10.3, −1.9 | 0.005 |